Jamie L. Reynoso, CEO, Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV), sold 50,296 shares at $2.58 ($130K) on 2025-07-03, disclosed to the SEC on 2025-07-08.
Scheduled sale ($130k) by CEO, Medicare Advantage under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.56 | 8,706 | $22K | 17.1% |
| 2 | $2.58 | 19,789 | $51K | 39.2% |
| 3 | $2.58 | 19,789 | $51K | 39.2% |
| 4 | $2.85 | 2,012 | $6K | 4.4% |
| Total | $2.59 avg | 50,296 | $130K | 100% |
| Filing → |
| CLOV | SELL | 2026-09-15 | $44K | — | Filing → |
| CLOV | SELL | 2026-07-17 | $22K | — | Filing → |
| CLOV | SELL | 2026-07-16 | $61K | — | Filing → |